Author:
Takada Minoru,Tada Mitsuhiro,Tamoto Eiji,Kawakami Akiko,Murakawa Katsuhiko,Shindoh Gaku,Teramoto Ken-ichi,Matsunaga Akihiro,Komuro Kazuteru,Kanai Motoshi,Fujiwara Yosie,Shirata Katsutoshi,Nishimura Norihiro,Miyamoto Masaki,Okushiba Shun-ichi,Kondo Satoshi,Hamada Jun-ichi,Katoh Hiroyuki,Yoshiki Takashi,Moriuchi Tetsuya
Reference27 articles.
1. Cancer statistics, 2001;Greenlee;CA Cancer J. Clin.,2001
2. The changing epidemiology of lung cancer in Europe;Janssen-Heijnen;Lung Cancer,2003
3. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma;Cerfolio;Ann. Thorac. Surg.,2003
4. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas;Hashimoto;Cancer Res.,1999
5. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines;Kelley;J. Natl. Cancer Inst.,1995